ELC Group

What ELC Group does

ELC Group is a private life sciences consulting and professional services firm founded in 2004 and headquartered in Karolinka, Czech Republic, with 101-250 employees. The firm delivers specialized regulatory, compliance, and product development services to pharmaceutical, biotechnology, medical device, and consumer healthcare companies across global markets. Its service portfolio spans five categories: Product Development (biopharmaceutical drug development, medical device and MedTech services, consumer healthcare including nutraceuticals, cosmetics, and dermatological solutions), Market and Patient Access Services (policy and advocacy, pricing strategy, health technology assessment, health economics and outcomes research, public affairs, and patient programs), Life Cycle Management (regulatory affairs and operations, quality and compliance, safety and vigilance), Strategy & Digital (strategic consulting, business transformation and commercial excellence, digital and IT services), and Innovation (digital innovation and healthcare and medical innovation). ELC Group operates as a B2B professional services business with a sales-led go-to-market model, engaging enterprise clients through direct relationships and project-based contracts. Revenue is generated through quote-based consulting engagements; no publicly disclosed pricing exists. The firm has been integrated into ProductLife Group (Groupe ProductLife S.A.), a privately held healthcare services parent, with all former ELC Group content migrated to the ProductLife Group website, indicating absorption rather than continued independent operations. No proprietary technology, AI capabilities, patents, certifications, or notable partnerships are disclosed in the available data. Leadership is led by CEO Marco Rubenstein.

Name

ELC Group

Legal name

ELC Group

Website

https://elc-group.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

101–250 employees

Short description

ELC Group is a life sciences consulting firm offering regulatory, compliance, product development, and market access services to pharmaceutical, medical device, and consumer healthcare companies, now operating as an integrated unit within ProductLife Group.

Ownership category

akta.pro rank

Product category

Life Sciences Consulting Services

NAICS

Management Consulting Services (54161)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

KOL Engagement & Medical Education (Advisory Boards/CME Support) (HLAGALAM)

Keywords

• Pharmaceutical consulting services
• Regulatory affairs services
• Medical device compliance
• Pharmacovigilance services
• Life sciences consulting

Headquarters

HQ city

Karolinka

HQ country

Czechia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Professional Services: Revenue generated through consulting and specialized services across product development, market access, regulatory affairs, quality compliance, safety vigilance, and strategic digital services for the pharmaceutical and healthcare industries.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

ELC Group delivers consulting and specialized services across the pharmaceutical, medical device, and consumer healthcare industries. Its offering spans product development (biopharmaceutical drug development, medical device/MedTech, nutraceuticals, cosmetics/dermatological), market and patient access services (policy, pricing, HTA, health economics, patient programs), life cycle management (regulatory affairs, quality/compliance, safety/vigilance), strategy & digital (consulting, business transformation, IT services), and innovation (digital and medical innovation). The company's offerings are now delivered through its parent, ProductLife Group.

Product overview

ELC Group is a life sciences consulting and services company offering an integrated portfolio of five service categories delivered through ProductLife Group. The portfolio includes Product Development (biopharmaceutical, medical device, and consumer healthcare services), Market and Patient Access Services (policy, pricing, HTA, and patient programs), Life Cycle Management (regulatory affairs, quality, safety), Strategy & Digital (consulting, transformation, IT services), and Innovation (digital and medical innovation). Former ELC Group information has been integrated into the ProductLife Group website.

Differentiator

Problem solved

Functional benefit

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights4 records

Direct peers

• Premier Research: Specialty CRO providing regulatory, clinical, and medical affairs services with particular strength in rare disease and MedTech — directly comparable niche competitor to ELC Group.
• Certara, Inc. Scientific and regulatory consulting firm providing model-informed drug development, regulatory submissions, and HEOR services. Highly comparable to ELC Group's regulatory affairs and health economics offerings.
• PharmaLex (Cencora): Specialized regulatory affairs, pharmacovigilance, and quality compliance consulting firm acquired by Cencora (formerly AmerisourceBergen). Closest direct competitor to ELC Group's core regulatory and safety vigilance practice.
• Parexel International: Global CRO with regulatory, clinical, pharmacovigilance, and market access services. Comparable service mix spanning product development through lifecycle management for pharma and MedTech clients.
• Worldwide Clinical Trials: Mid-sized global CRO with regulatory, clinical, and pharmacovigilance services for biopharma and MedTech — comparable size segment and service mix to ELC Group's specialized practice.
• Medpace Holdings: Mid-to-large CRO providing clinical development, regulatory affairs, and pharmacovigilance services with a similar B2B professional services model to ELC Group.
• ICON plc: Global CRO with dedicated regulatory affairs, pharmacovigilance, and consulting services for pharma and biotech. Direct competitor for ELC Group's lifecycle and regulatory offerings at significantly greater scale.
• ProPharma Group: Specialist regulatory compliance, pharmacovigilance, and quality consulting firm for pharma, biotech, and medical device companies. Highly comparable mid-sized specialist competitor.

Broad incumbents

• Charles River Laboratories: Broadly diversified CRO with regulatory and safety assessment services alongside preclinical and clinical offerings. Overlaps ELC Group on the regulatory and lifecycle management service lines.

Others

• IQVIA: Largest global life sciences services company with regulatory, HTA, HEOR, pharmacovigilance, and market access capabilities — overlaps ELC Group across most service lines but operates at vastly greater scale and breadth.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/elc_group

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ELC Group